MDTW Module 3: Beyond A1C: Understanding Time in Range, a New Continuous Glucose Monitoring

MDTW Module 3: Beyond A1C: Understanding Time in Range, a New Continuous Glucose Monitoring–Derived Metric for Assessing Glycemia

Overview

Learning Objectives:
•Discuss the limitations of A1C in assessing glycemic management in diabetes.
•Define continuous glucose monitoring (CGM)–derived glycemia metrics such as time in range (TIR), time above range (TAR), and time below range (TBR).
•Identify the components of the ambulatory glucose profile (AGP) standardized CGM report.
•Apply a systematic approach to reviewing the AGP to guide therapeutic decision-making.

Viral N. Shah, MD
Associate Professor of Medicine and Pediatrics
Barbara Davis Center for Diabetes
University of Colorado Anschutz Medical Campus
Denver, CO

Disclosures:
•Advisory boards: Medscape LLC and Sanofi US
•Speaker: Dexcom and Insulet Corp
•Director, Diabetes Dialog: a 3-day educational program for endocrine fellows, sponsored by Abbott, Dexcom, Eversense, Insulet, Medtronic, and Tandem
•Research funding: Abbott, Dexcom, Eli Lilly and Co., JDRF, National Institutes of Health, Novo Nordisk, Insulet, and Sanofi

Duration: 45 minutes

Summary


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered

Create Account